FDA Emergency Use Authorization for SARS-CoV-2 N Protein Antigen

88
Quanterix Receives FDA Emergency Use Authorization for SARS-CoV-2 N Protein Antigen Test

As case counts and positivity rates rise globally, the COVID-19 testing landscape is of critical importance

finance.yahoo.com/news/quanterix-receives-fda-emergency-authorization-213000735.html

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.